Breaking: Athens airport nears capacity before UGA-Texas game, flights to be rerouted
COVID-19
COVID-19

J&J: Booster dose of its COVID shot prompts strong response

Johnson & Johnson's COVID-19 Vaccine Is 66% Effective in Global Trial.The single-shot vaccine was found to be 66% effective against moderate to severe illness in a global phase 3 trial.Against severe disease, the vaccine was 85% effective globally in adults of all ages and racial groups.In the United States, the vaccine was 72% effective against moderate and severe disease.Despite other vaccines being around 95% effective, experts say the Johnson & Johnson vaccine will still be useful.A vaccine that's inexpensive, that's a single dose, and that has no cold chain requirements — that's pretty good. , Dr. Anthony Fauci, via CNN.Johnson & Johnson is set to apply for emergency use authorization through the U.S. Food and Drug Administration next week, hoping for a late February rollout
By The Associated Press
Sept 21, 2021

LONDON — Johnson & Johnson released data showing that a booster dose to its one-shot coronavirus vaccine provides a strong immune response months after people receive a first dose.

J&J said in statement Tuesday that it ran two early studies in people previously given its vaccine and found that a second dose produced an increased antibody response in adults from ages 18 to 55. The study’s results haven’t yet been peer-reviewed.

ExploreComplete coverage: Coronavirus

“A booster dose of the Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine,” said Dr. Mathai Mammen, global head of research and development at J&J.

The company is in talks with regulators including the U.S. Food and Drug Administration, the European Medicines Agency and others regarding using booster doses of its vaccine.

More Stories

The Latest

What's the difference between the coronavirus, the cold and influenza?

Coronavirus, cold or the flu? Here’s how to tell the difference

UPDATED: Coronavirus in Georgia: COVID-19 Dashboard

As pandemic ends, so could your Medicaid coverage: What to know in Georgia

Featured

Prosecutor Skandalakis has previously suggested that pursuing criminal charges against President Donald Trump may not be feasible until after he leaves office in 2029. (Craig Hudson/Politico/Bloomberg via Getty Images)

Credit: Bloomberg via Getty Images

Prosecutor takes helm of Georgia case against Trump. But will he move forward?

A veteran Georgia prosecutor will decide the fate of Fulton County District Attorney Fani Willis' election interference case against Donald Trump and his allies.

With some solar power tax breaks expiring, Georgians rush to catch the sun

Georgia solar installers say they’re seeing a surge of customers trying to install rooftop solar systems before federal tax credits go away at the end of the year.

‘Automatic for the People’: Weaver D’s still bonds Athens as era nears end

After feeding everyone from R.E.M. to Brian Kemp, and coining a phrase that went global, Dexter Weaver is preparing to close his storied Athens soul food restaurant.